Last month, I wrote that Americans tend to be more concerned than excited about AI advances. Today, I’m sharing ideas for what we can do to ease those concerns and build the kind of trust that gets people excited about what’s ahead.
Thanks to @KevinTFrazier for having me on @scaling_laws. Great to discuss how the right governance frameworks can help capture AI’s massive potential.
We don’t have to choose between over-regulation and no regulation—there’s a thoughtful middle way.
This is why we call AI tools a breakthrough in driving breakthroughs:
▶️ A new survey shows AI is slashing early-stage drug development timelines and costs by up to 70%
▶️ New drug development programs could grow by more than 10% in three to five years
(1/2) When it comes to AI’s economic impact, uncertainty abounds.
Recently in @nytimes, Ben Casselman noted that researchers can’t even agree on basic questions like how many companies are using AI, which workers might be affected, or how.
The Genesis Mission sets a bold ambition to double scientific productivity within the decade and harness AI to accelerate the pace of discovery.
Today we’re building on our commitments to the Genesis Mission with $40M in cloud credits and AI tools. ↓